{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:33:15Z","timestamp":1790073195763,"version":"4.0.1"},"reference-count":49,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,12,23]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>HA-specific iPSC-derived ECs overexpress full-length F8 after genetic engineering via a piggyBac transposon system. Bioengineered microvascular grafts deliver full-length FVIII into the bloodstream and restore hemostasis in hemophilic SCID mice.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019000848","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T11:32:37Z","timestamp":1576668757000},"page":"4166-4176","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":17,"title":["Bioengineering hemophilia A\u2013specific microvascular grafts for delivery of full-length factor VIII into the bloodstream"],"prefix":"10.1182","volume":"3","author":[{"given":"Joseph","family":"Neumeyer","sequence":"first","affiliation":[{"name":"Department of Cardiac Surgery, Boston Children\u2019s Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9020-8144","authenticated-orcid":false,"given":"Ruei-Zeng","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Boston Children\u2019s Hospital, Boston, MA;"},{"name":"Department of Surgery, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6240-0147","authenticated-orcid":false,"given":"Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Boston Children\u2019s Hospital, Boston, MA;"},{"name":"Department of Surgery, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0804-672X","authenticated-orcid":false,"given":"Xuechong","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Boston Children\u2019s Hospital, Boston, MA;"},{"name":"Department of Surgery, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien","family":"Hua","sequence":"additional","affiliation":[{"name":"Dana-Farber\/Boston Children\u2019s Cancer and Blood Disorders Center, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6112-6166","authenticated-orcid":false,"given":"Stacy E.","family":"Croteau","sequence":"additional","affiliation":[{"name":"Dana-Farber\/Boston Children\u2019s Cancer and Blood Disorders Center, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8092-6281","authenticated-orcid":false,"given":"Ellis J.","family":"Neufeld","sequence":"additional","affiliation":[{"name":"Dana-Farber\/Boston Children\u2019s Cancer and Blood Disorders Center, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4689-8149","authenticated-orcid":false,"given":"Juan M.","family":"Melero-Martin","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Boston Children\u2019s Hospital, Boston, MA;"},{"name":"Department of Surgery, Harvard Medical School, Boston, MA;"},{"name":"Harvard Stem Cell Institute, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2019,12,18]]},"reference":[{"issue":"6018","key":"2019123016430854400_B1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/315427a0","article-title":"Detection and sequence of mutations in the factor VIII gene of haemophiliacs","volume":"315","author":"Gitschier","year":"1985","journal-title":"Nature"},{"issue":"2","key":"2019123016430854400_B2","first-page":"437","article-title":"Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators","volume":"96","author":"Soucie","year":"2000","journal-title":"Blood"},{"issue":"3","key":"2019123016430854400_B3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJMoa1208024","article-title":"Factor VIII products and inhibitor development in severe hemophilia A","volume":"368","author":"Gouw","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"2019123016430854400_B4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2516.2011.02643.x","article-title":"Health-related quality of life and psychological well-being in elderly patients with haemophilia","volume":"18","author":"von Mackensen","year":"2012","journal-title":"Haemophilia"},{"issue":"5","key":"2019123016430854400_B5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2516.2012.02791.x","article-title":"Quality of life in haemophilia A: Hemophilia Utilization Group Study Va (HUGS-Va)","volume":"18","author":"Poon","year":"2012","journal-title":"Haemophilia"},{"issue":"1","key":"2019123016430854400_B6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2516.2006.01192.x","article-title":"Compliance with treatment and understanding of own disease in patients with severe and moderate haemophilia","volume":"12","author":"Lindvall","year":"2006","journal-title":"Haemophilia"},{"issue":"5","key":"2019123016430854400_B7","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1365-2516.2009.02036.x","article-title":"Factor VIII prophylaxis for adult patients with severe haemophilia A: results of a US survey of attitudes and practices","volume":"15","author":"Walsh","year":"2009","journal-title":"Haemophilia"},{"issue":"5","key":"2019123016430854400_B8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MOH.0b013e32833cd4bd","article-title":"Preclinical and clinical progress in hemophilia gene therapy","volume":"17","author":"M\u00e1trai","year":"2010","journal-title":"Curr Opin Hematol"},{"issue":"11","key":"2019123016430854400_B9","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1089\/hum.2017.116","article-title":"Hemophilia gene therapy: ready for prime time?","volume":"28","author":"VandenDriessche","year":"2017","journal-title":"Hum Gene Ther"},{"issue":"5","key":"2019123016430854400_B10","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1073\/pnas.1015571108","article-title":"Neonatal helper-dependent adenoviral vector gene therapy mediates correction of hemophilia A and tolerance to human factor VIII","volume":"108","author":"Hu","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019123016430854400_B11","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood-2003-05-1426","article-title":"Helper-dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia A","volume":"103","author":"Brown","year":"2004","journal-title":"Blood"},{"issue":"4","key":"2019123016430854400_B12","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1182\/blood-2003-08-2954","article-title":"Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype","volume":"103","author":"Sarkar","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2019123016430854400_B13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1182\/blood-2005-12-5115","article-title":"Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs","volume":"108","author":"Jiang","year":"2006","journal-title":"Blood"},{"issue":"6","key":"2019123016430854400_B14","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1089\/hum.2007.0182","article-title":"Complete correction of hemophilia A with adeno-associated viral vectors containing a full-size expression cassette","volume":"19","author":"Lu","year":"2008","journal-title":"Hum Gene Ther"},{"issue":"23","key":"2019123016430854400_B15","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1182\/blood-2012-05-423210","article-title":"The gene therapy journey for hemophilia: are we there yet?","volume":"120","author":"High","year":"2012","journal-title":"Blood"},{"issue":"6","key":"2019123016430854400_B16","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1365-2516.2009.02026.x","article-title":"Functional roles of the factor VIII B domain","volume":"15","author":"Pipe","year":"2009","journal-title":"Haemophilia"},{"issue":"6","key":"2019123016430854400_B17","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1538-7836.2005.01389.x","article-title":"The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor","volume":"3","author":"Bovenschen","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2019123016430854400_B18","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1182\/blood-2003-10-3591","article-title":"Bioengineering of coagulation factor VIII for improved secretion","volume":"103","author":"Miao","year":"2004","journal-title":"Blood"},{"issue":"2","key":"2019123016430854400_B19","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1538-7836.2007.02346.x","article-title":"Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A","volume":"5","author":"Shi","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2019123016430854400_B20","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1182\/blood-2008-02-138214","article-title":"Syngeneic transplantation of hematopoietic stem cells that are genetically modified to express factor VIII in platelets restores hemostasis to hemophilia A mice with preexisting FVIII immunity","volume":"112","author":"Shi","year":"2008","journal-title":"Blood"},{"issue":"3","key":"2019123016430854400_B21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood-2013-08-520478","article-title":"Platelet gene therapy corrects the hemophilic phenotype in immunocompromised hemophilia A mice transplanted with genetically manipulated human cord blood stem cells","volume":"123","author":"Shi","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2019123016430854400_B22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1182\/blood.V99.2.457","article-title":"Use of blood outgrowth endothelial cells for gene therapy for hemophilia A","volume":"99","author":"Lin","year":"2002","journal-title":"Blood"},{"issue":"23","key":"2019123016430854400_B23","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1056\/NEJM200106073442301","article-title":"Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A","volume":"344","author":"Roth","year":"2001","journal-title":"N Engl J Med"},{"issue":"12","key":"2019123016430854400_B24","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/nprot.2012.115","article-title":"Generation of human induced pluripotent stem cells from urine samples","volume":"7","author":"Zhou","year":"2012","journal-title":"Nat Protoc"},{"issue":"5","key":"2019123016430854400_B25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nmeth.1591","article-title":"A more efficient method to generate integration-free human iPS cells","volume":"8","author":"Okita","year":"2011","journal-title":"Nat Methods"},{"issue":"1","key":"2019123016430854400_B26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/jth.12076","article-title":"Biochemical and functional characterization of a recombinant monomeric factor VIII-Fc fusion protein","volume":"11","author":"Peters","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2019123016430854400_B27","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.cell.2015.06.052","article-title":"Resetting transcription factor control circuitry toward ground-state pluripotency in human","volume":"162","author":"Takashima","year":"2015","journal-title":"Cell"},{"issue":"3","key":"2019123016430854400_B28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ymeth.2012.01.006","article-title":"Fibroblast growth factor-2 facilitates rapid anastomosis formation between bioengineered human vascular networks and living vasculature","volume":"56","author":"Lin","year":"2012","journal-title":"Methods"},{"issue":"2","key":"2019123016430854400_B29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5493\/wjem.v2.i2.30","article-title":"Standardizing a simpler, more sensitive and accurate tail bleeding assay in mice","volume":"2","author":"Liu","year":"2012","journal-title":"World J Exp Med"},{"issue":"3","key":"2019123016430854400_B30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1172\/JCI1250","article-title":"Intracellular trafficking of factor VIII to von Willebrand factor storage granules","volume":"101","author":"Rosenberg","year":"1998","journal-title":"J Clin Invest"},{"issue":"16","key":"2019123016430854400_B31","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2016-04-713289","article-title":"Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A","volume":"128","author":"Pipe","year":"2016","journal-title":"Blood"},{"issue":"28","key":"2019123016430854400_B32","doi-asserted-by":"crossref","first-page":"10137","DOI":"10.1073\/pnas.1405388111","article-title":"Human endothelial colony-forming cells serve as trophic mediators for mesenchymal stem cell engraftment via paracrine signaling","volume":"111","author":"Lin","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"2019123016430854400_B33","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1182\/blood-2011-08-372946","article-title":"Induction of erythropoiesis using human vascular networks genetically engineered for controlled erythropoietin release","volume":"118","author":"Lin","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2019123016430854400_B34","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm0603-685","article-title":"Molecular regulation of vessel maturation","volume":"9","author":"Jain","year":"2003","journal-title":"Nat Med"},{"issue":"8","key":"2019123016430854400_B35","doi-asserted-by":"crossref","first-page":"e104957","DOI":"10.1371\/journal.pone.0104957","article-title":"Delivery of full-length factor VIII using a piggyBac transposon vector to correct a mouse model of hemophilia A","volume":"9","author":"Matsui","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"2019123016430854400_B36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.mt.6300028","article-title":"PiggyBac transposon-mediated gene transfer in human cells","volume":"15","author":"Wilson","year":"2007","journal-title":"Mol Ther"},{"issue":"10","key":"2019123016430854400_B37","doi-asserted-by":"crossref","first-page":"e0140740","DOI":"10.1371\/journal.pone.0140740","article-title":"Factor VIII is synthesized in human endothelial cells, packaged in Weibel-Palade bodies and secreted bound to ULVWF strings","volume":"10","author":"Turner","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"2019123016430854400_B38","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1073\/pnas.0812090106","article-title":"Phenotypic correction of murine hemophilia A using an iPS cell-based therapy","volume":"106","author":"Xu","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2019123016430854400_B39","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.stemcr.2018.10.012","article-title":"Patient-specific iPSC-derived endothelial cells provide long-term phenotypic correction of hemophilia A","volume":"11","author":"Olgasi","year":"2018","journal-title":"Stem Cell Reports"},{"issue":"26","key":"2019123016430854400_B40","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1182\/blood-2013-12-545780","article-title":"Omental implantation of BOECs in hemophilia dogs results in circulating FVIII antigen and a complex immune response","volume":"123","author":"Ozelo","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2019123016430854400_B41","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.stem.2015.07.001","article-title":"Functional correction of large factor VIII gene chromosomal inversions in hemophilia A patient-derived iPSCs using CRISPR-Cas9","volume":"17","author":"Park","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"12","key":"2019123016430854400_B42","doi-asserted-by":"crossref","first-page":"e83280","DOI":"10.1371\/journal.pone.0083280","article-title":"A novel cell-sheet technology that achieves durable factor VIII delivery in a mouse model of hemophilia A","volume":"8","author":"Tatsumi","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"2019123016430854400_B43","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1634\/stemcells.2006-0699","article-title":"Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors","volume":"25","author":"Matsui","year":"2007","journal-title":"Stem Cells"},{"issue":"5","key":"2019123016430854400_B44","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1182\/bloodadvances.2018027979","article-title":"FVIII expression by its native promoter sustains long-term correction avoiding immune response in hemophilic mice","volume":"3","author":"Merlin","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"2019123016430854400_B45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/mthe.2000.0224","article-title":"Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain","volume":"3","author":"Thomas","year":"2001","journal-title":"Mol Ther"},{"issue":"3","key":"2019123016430854400_B46","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2516.2009.02010.x","article-title":"Gene therapy for haemophilia...yes, but...with non-viral vectors?","volume":"15","author":"Liras","year":"2009","journal-title":"Haemophilia"},{"issue":"5","key":"2019123016430854400_B47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood-2018-07-820720","article-title":"Update on clinical gene therapy for hemophilia","volume":"133","author":"Perrin","year":"2019","journal-title":"Blood"},{"issue":"11","key":"2019123016430854400_B48","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1182\/blood.V81.11.2925.2925","article-title":"Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII","volume":"81","author":"Pittman","year":"1993","journal-title":"Blood"},{"issue":"6","key":"2019123016430854400_B49","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1177\/0963689718759474","article-title":"Bioengineering with endothelial progenitor cells improves the vascular engraftment of transplanted human islets","volume":"27","author":"Grapensparr","year":"2018","journal-title":"Cell Transplant"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/24\/4166\/1550533\/advancesadv2019000848.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/24\/4166\/1550533\/advancesadv2019000848.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T16:43:25Z","timestamp":1577724205000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/3\/24\/4166\/429666\/Bioengineering-hemophilia-Aspecific-microvascular"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,18]]},"references-count":49,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2019,12,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019000848","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,18]]}}}